Structural diversity of bile salt hydrolases reveals rationale for substrate selectivity
Walker, M.E., Redinbo, M.R.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Choloylglycine hydrolase | 338 | Bacteroidales | Mutation(s): 0  | ![]() | |
Entity Groups   | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
| |||||
| Ligands 1 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| WSR (Subject of Investigation/LOI) Query on WSR | E [auth A], F [auth B], G [auth C], H [auth D] | (1R,3aS,3bR,5aR,7R,9aS,9bS,11aR)-1-[(2R)-6-fluoro-5-oxohexan-2-yl]-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-7-yl hydrogen sulfate (non-preferred name) C25 H41 F O5 S MVPISWRWXKQVBV-CIQXVCGBSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 63.142 | α = 90 |
| b = 66.812 | β = 90 |
| c = 321.831 | γ = 90 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
| PHENIX | refinement |
| XDS | data reduction |
| XDS | data scaling |
| PHASER | phasing |
| Funding Organization | Location | Grant Number |
|---|---|---|
| National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) | United States | GM135218 |